retatrutide phase 2 nejm 2023 obesity trial jastreboff Are you seeing fewer bariatric cases? Tirzepatide may be similar to surgery, and https://www.nejm.org/doi/full/10.1056/NEJMoa2301972 (not yet approved in US but people using anyway) promises even potentially greater weight loss amongst the Retatrutide vs Wegovy: which works

Glutatyon, solunum yoluyla alndnda akcier fonksiyonlarn desteklemek iin kullanlabilir

A patient with unexplained fatigue should be worked up, not injected masking a B12 deficiency of unclear cause, or an unexamined thyroid problem, with a monthly shot is a real clinical risk

Peer review Peer review information Nature Reviews Endocrinology thanks Thomas Lutz and the other, anonymous, reviewer(s) for their contribution to the peer review of this work

While calorie burning remains relevant, the primary benefits involve preserving lean tissue, maintaining bone density, managing mood fluctuations, improving sleep quality, and reducing cardiovascular risk